The assessment of HER2 status in breast cancer: the past, the present, and the future.
about
Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast CancerBacterial Toxins for Cancer Therapy.In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells.Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer.HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma.Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation.Correlation of Immunohistochemistry and Fluorescence in Situ Hybridization for HER-2 Assessment in Breast Cancer Patients: Single Centre Experience.
P2860
Q28072513-236058A7-2DA5-44AC-B3B6-E9813EE69381Q40101895-04DBEB01-3417-4BC6-84A7-D16561525C7DQ45753940-1E72B771-CBA8-432F-ACB0-ECB580D14225Q46225087-891EFFFC-EAE5-405E-B95E-4236D8947EC9Q47549277-A818A730-FE36-4492-B235-B9C0AB8366D7Q47965547-17CB795A-6624-4873-88B0-74EE59906EABQ52098663-FA7882FC-677F-4F2A-9B5A-9B6947DC6081Q53825199-DB0A95B4-52A7-4CDF-9A6D-472BA98865E9
P2860
The assessment of HER2 status in breast cancer: the past, the present, and the future.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The assessment of HER2 status in breast cancer: the past, the present, and the future.
@en
type
label
The assessment of HER2 status in breast cancer: the past, the present, and the future.
@en
prefLabel
The assessment of HER2 status in breast cancer: the past, the present, and the future.
@en
P2093
P2860
P356
P1476
The assessment of HER2 status in breast cancer: the past, the present, and the future.
@en
P2093
Craig Allred
Eslie Dennis
Hiroaki Nitta
Peter Banks
Suzan Jewell
Thomas M Grogan
P2860
P304
P356
10.1111/PIN.12407
P577
2016-04-07T00:00:00Z